V014-5699 Screening compound: N-(3-METHYLBUTYL)-3-[2-(MORPHOLIN-4-YL)-2-OXOETHYL]-8-(TRIFLUOROMETHYL)-1H,2H,3H,4H,4AH,5H,6H-PYRAZINO[1,2-A]QUINOLINE-5-CARBOXAMIDE

V014-5699 Screening compound: N-(3-METHYLBUTYL)-3-[2-(MORPHOLIN-4-YL)-2-OXOETHYL]-8-(TRIFLUOROMETHYL)-1H,2H,3H,4H,4AH,5H,6H-PYRAZINO[1,2-A]QUINOLINE-5-CARBOXAMIDE
V014-5699 Screening compound: N-(3-METHYLBUTYL)-3-[2-(MORPHOLIN-4-YL)-2-OXOETHYL]-8-(TRIFLUOROMETHYL)-1H,2H,3H,4H,4AH,5H,6H-PYRAZINO[1,2-A]QUINOLINE-5-CARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound V014-5699
N-(3-METHYLBUTYL)-3-[2-(MORPHOLIN-4-YL)-2-OXOETHYL]-8-(TRIFLUOROMETHYL)-1H,2H,3H,4H,4AH,5H,6H-PYRAZINO[1,2-A]QUINOLINE-5-CARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V014-5699

Molecular Formula

C25H35F3N4O3 (C25 H35 F3 N4 O3)

Compound Name

N-(3-METHYLBUTYL)-3-[2-(MORPHOLIN-4-YL)-2-OXOETHYL]-8-(TRIFLUOROMETHYL)-1H,2H,3H,4H,4AH,5H,6H-PYRAZINO[1,2-A]QUINOLINE-5-CARBOXAMIDE

IUPAC name

n/a

SMILES

CC(C)CCNC(C(C1)C(CN(CC(N2CCOCC2)=O)CC2)N2c2c1cc(C(F)(F)F)cc2)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

496.57

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.480

Distribution Coefficient, logD

2.428

Water Solubility, LogSw

-2.94

Polar Surface Area

54.911

Acid Dissociation Constant (pKa)

12.94

Base Dissociation Constant (pKb)

6.51

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

68.00

V014-5699 in Drug Discovery

Included in Screening Libraries

Bromodomain Modulators Library (5801 compounds)

PI3K-Targeted Library (17255 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Nervous system
  • Cardiovascular
Targets:
  • Kinases
  • Ion Channels

References: we are preparing a list of scientific research reports with V014-5699 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V014-5699?
Check Price and Availability of V014-5699, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V014-5699 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V014-5699
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V014-5699
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V014-5699 available by request